英文総説・著書
Ikegami H, Babaya N, Noso S:
Beta-cell failure in diabetes: common susceptibility and mechanisms shared between type 1 and type 2 diabetes
J Diabetes Investig. 12: 1526-1539, 2021
原著論文
Renard E, Ikegami H, Vianna A, Pozzilli P, Brette S, Bosnyak Z, Lauand F, Peters A, Pilorget V, Jurisic-Eizen D, Kesavadev J, Seufert J, Wilmot E:
The SAGE study: global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM
Diabetes/Metabolism Research and Reviews 37: e3430, 2021
Niwano F, Babaya N, Hiromine Y, Matsumoto I, Kamei K, Noso S, Taketomo Y, Takeyama Y, Kawabata Y, Ikegami H:
Glucose metabolism after pancreatectomy: opposite extremes between pancreaticoduodenectomy and distal pancreatectomy
J Clin Endocrinol Metab.106:e2203-e2214, 2021
Babaya N, Noso S, Hiromine Y, Taketomo Y, Niwano F, Yoshida S, Yasutake S, Kawabata Y, Ikegami H:
Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes
Scientific Reports 11:4006, 2021
Monobe K, Noso S, Babaya N, Hiromine Y, Taketomo Y, Niwano F, Yoshida S, Yasutake S, Minohara T, Kawabata Y, Ikegami H:
Clinical and genetic determinants of urinary glucose excretion in patients with diabetes mellitus
J Diabetes Investig. 12: 728-737, 2021
Minohara T, Noso S, Babaya N, Hiromine Y, Taketomo Y, Niwano F, Makutani Y, Yoshida S, Yasutake S, Imamura S, Ikegami H:
Associations between genetic loci related to lean mass and body composition in type 2 diabetes.
Geriatr Gerontol Int. 21: 932-938, 2021
Sugimoto K, Ikegami H, Takata Y, Katsuya T, Fukuda M, Akasaka H, Tabara Y, Osawa H, Hiromine Y, Rakugi H:
Glycemic control and insulin improve muscle mass and gait speed in type 2 diabetes: the MUSCLES-DM study.
J Am Med Dir Assoc. 22: 834-838, 2021
Babaya N, Noso S, Hiromine Y, Taketomo Y, Niwano F, Monobe K, Imamura S, Ueda K, Yamazaki Y, Sasano H, Ikegami H:
Oncocytic adrenocortical carcinoma with low 18F-FDG uptake and the absence of glucose transporter 1 expression.
J Endocr Soc. 5: bvab143, 2021
Yoshida S, Babaya N, Ito H, Hiromine Y, Taketomo Y, Niwano F, Imamura S, Yamazaki Y, Sasano H, Kawabata Y, Noso S, Ikegami H:
Mixed corticomedullary tumor accompanied by unilateral aldosterone-producing adrenocortical micronodules: A case report
J Endocr Soc. 5: bvab140, 2021
Tateishi R, Matumura T, Okanoue T et al.：
Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan.
J Gastroenterol. 56: 261-273, 2021
Katsuno T, Shiraiwa T, Iwasaki S, Park H, Watanabe N, Kaneko S, Terasaki J, Hanafusa T, Imagawa A, Shimomura I, Ikegami H, Koyama H, Namba M, Miyagawa JI, For the TRUST2 study group:
Benefit of Early Add-on of Linagliptin to Insulin in Japanese Patients With Type 2 Diabetes Mellitus: Randomized-Controlled Open-Label Trial (TRUST2)
Adv Ther. 5.38:1514–1535, 2021
Abiru N, Shimada A, Nishimura R, Matsuhisa M, Ozaki A, Ikegami H:
Glycemic control status, diabetes management patterns, and clinical characteeristics of adults with type 1 diabetes in Japan: Study of Adults' Glycemia in T1DM subanalysis.
Diabetol Int. 12:460-473, 2021
Chujo D, Imagawa A, Yasuda K, Abiru N, Awata T, Fukui T, Ikegami H, Kawasaki E, Katsuki T, Kobayashi T, Kozawa J, Nagasawa K, Ohtsu H, Oikawa Y, Osawa H, Shimada A, Shimoda M, Takahashi K, Tsuchiya K, Tsujimoto T, Yasuda H, Hanafusa T, Kajio H
Japanese Type 1 Diabetes Database Study (TIDE-J): rational and study design
Diabetol Int. 13: 288-294, 2021
英文
2020/12/22 13:54
